Pacific Health Ventures

Pacific Health Ventures is a venture capital firm established in 2019 and located in Menlo Park, California. The firm focuses on investing in early-stage companies within the healthcare technology sector, particularly those that develop B2B software-as-a-service platforms. Its investment strategy aims to enhance clinical outcomes, streamline workflows, and generate new revenue opportunities, ultimately improving the experiences of both patients and healthcare professionals.

Chris Furmanski

Managing Director

6 past transactions

Relief Cardiovascular

Series A in 2025
Relief Cardiovascular is a medical technology company focused on developing an innovative smart implant aimed at treating congestive heart failure. The company's implantable device is designed to monitor blood flow and alleviate congestion in the heart, thereby improving health outcomes for patients suffering from this condition. By providing a targeted treatment option, Relief Cardiovascular aims to enhance the quality of life for individuals with heart failure.

Feeling Great

Seed Round in 2024
Feeling Great is a digital health company that specializes in mental health support. It offers an app featuring an AI-powered chatbot, interactive courses, self-help exercises, and evidence-based treatment information. The platform aims to help individuals manage depression and anxiety, build coping mechanisms, and enhance overall well-being.

Sika Health

Seed Round in 2022
Sika Health is a New York-based company founded in 2021 that specializes in payment solutions for the healthcare sector. It develops technology that integrates health wallets, allowing users to manage expenses related to medical bills, dental care, medications, and other health-related costs. By partnering with health and wellness brands, Sika Health's platform facilitates customer engagement at the point of sale, enabling consumers to utilize their health benefits accounts effectively. This innovative approach not only minimizes the risk of cart abandonment but also supports users in making financially sound decisions that align with their long-term health objectives.

Limbix

Series A in 2021
Limbix is a prescription digital therapeutic company focused on developing innovative mental health treatments specifically for adolescents. The company offers a digital therapeutics platform designed to address the mental health challenges faced by young people, including depression and anxiety. Limbix's first product, SparkRx, enables licensed healthcare professionals to prescribe evidence-based, therapeutic interventions to improve the mental well-being of their patients. The diverse team at Limbix, consisting of clinicians, product designers, researchers, and engineers, combines clinical expertise with technological innovation to create effective digital solutions for adolescent mental health.

Safely You

Series A in 2021
SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

WinterLight Labs

Series A in 2019
WinterLight Labs Inc. is a Toronto-based company founded in 2015 that specializes in developing a speech-based platform for the detection and monitoring of cognitive and mental diseases, including dementia and Alzheimer's disease. The company's innovative AI technology analyzes natural speech samples to quantify various speech and language patterns, enabling the accurate assessment of cognitive health. By utilizing a brief one-minute speech sample, WinterLight's platform can characterize aspects such as lexical diversity, syntactic complexity, semantic content, and articulation, effectively capturing the speaker's cognitive state. This diagnostic tool has significant applications across clinical trials, long-term care, primary care, and speech-language pathology, facilitating the early detection of cognitive impairment and tracking disease progression.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.